Randomized, Double-Blind, Placebo-Controlled Phase II Trail of the Safety, Tolerability and Immunology of Lyophilized Chimerivax TM-WN02 West Nile Vaccine in Healthy Adults; Safety and Effectiveness of West Nile Vaccine in Healthy Adults

Grants and Contracts Details

StatusFinished
Effective start/end date3/1/062/28/14

Funding

  • Origin Pharmaceutical Services Ltd: $123,768.00